NASHVILLE, Tennessee — Representatives from LGM Pharma, a leading supplier of active pharmaceutical ingredients to various global pharmaceutical firms, headquartered in Nashville, Tennessee with administrative offices in Boca Raton, Florida, recently attended the CPhI Worldwide conference in Madrid, Spain. CPhI is the world’s leading pharmaceutical platform that brings together pharma ingredients manufacturers, suppliers and buyers. The conference agenda tackled the most timely and business critical issues facing the pharmaceutical industry today.
During the conference, representatives of LGM Pharma met with strategic manufacturers to discuss involvement in the development of commercial products. Industry updates and information were exchanged and insight into various regulatory industry intelligence was shared.
According to Mendy Schurder, LGM Director and COO, “By attending the CPhI conference, we had the opportunity to gather the latest market trends, explore key case study insights and benefit from exceptional networking opportunities all within three days. Although we had a full meeting schedule, LGM considers this the most vital venue to meet with clients, manufacturers and potential new business partners.”
“Given the limited time with each business partner, LGM was still able to have meetings with, and come away with, key commitments to some late phase development projects with a specialty pharma client in the new drug delivery space,” said Robert Hoppes, LGM Director of Sales. “Our industry experience enables us to support our clients throughout the entire pathway of drug development, from drug discovery through commercial production.”
“In today’s world, international business is easily accomplished, where everything is readily accessible and instantaneous,” stated Albert Miseje, LGM Vice president, New Business Development. “However, it’s still essential to go back to the basics and conduct face to face meetings. This value still holds true today.”
The CPhI Worldwide conference hosted over 36,000 visiting pharma professionals, 2,500 exhibitors from more than 150 countries and more than 100 industry seminars, covering every sector in four massive halls.
LGM Pharma is a leading supplier of active pharmaceutical ingredients (APIs) to Contract manufacturers and various global pharmaceutical firms involved in the manufacturing, research and development of a wide range of therapeutic chemical entities. In its commitment to improving health opportunities all over the world, LGM Pharma has forged partnerships with some of the biggest names in the pharmaceutical industry. Currently, the company supplies over 2,500 active pharmaceutical ingredients to its global clients.